VikCoVac Study

January 7, 2016

Do you have diabetes? Would you like to participate in a research trial?

Royal Perth Hospital Winthrop Professor of Cardiology Carl Schultz is conducting a research study called VikCoVac to investigate the effects of Vitamin K and Colchicine on vascular calcification activity.

The VikCoVac study:

  • is conducted on-site at Royal Perth Hospital in partnership with The University of Western Australia
  • allows participants to continue their current medications throughout the study
  • has no costs associated with participation.

To see if you are an eligible candidate or for more information please contact the Royal Perth Hospital Cardiology Research team on (08) 9224 3181 or 0474 738 890. Take a look at a recent feature on Today Tonight (external link) for more information.

This study has been approved by the Royal Perth Hospital Human Research Ethics Committee.

Download the ViKCoVaC study brochure (PDF 292kB) for more information.